本页面由Tiger Trade Technology Pte. Ltd.提供服务

Standard BioTools Inc.

0.8973
-0.0607-6.34%
成交量:248.21万
成交额:225.96万
市值:3.50亿
市盈率:-4.57
高:0.9582
开:0.9512
低:0.8950
收:0.9580
52周最高:1.72
52周最低:0.8950
股本:3.90亿
流通股本:2.17亿
量比:1.55
换手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-0.1963
每股收益(LYR):-0.1963
净资产收益率:-13.13%
总资产收益率:-9.88%
市净率:0.82
市盈率(LYR):-4.57

数据加载中...

2024/03/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/01/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/20

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/01/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]